FOXO1 is regulated by insulin and IGF1 in pituitary gonadotropes

Molecular and Cellular Endocrinology

Volumn 405, Issue , 2015, Pages 14-24

  Skarra, Danalea V ^a   Thackray, Varykina G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Forkhead box O1; GnRH; Gonadotrope; IGF1; Insulin

Indexed keywords

GONADORELIN; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT HUMAN INSULIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR FKHR; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; INSULIN-LIKE GROWTH FACTOR-1, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; GONADOTROPIN RELEASE; GONADOTROPIN SECRETING CELL; HYPOPHYSIS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING;

ANIMALS; CELL LINE; FORKHEAD TRANSCRIPTION FACTORS; GONADOTROPHS; GONADOTROPIN-RELEASING HORMONE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MICE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84922998613     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.02.006     Document Type: Article

References (82)

1. Adashi E.Y., Hsueh A.J., Yen S.S. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 1981, 108:1441-1449.
2. Alarid E.T., Windle J.J., Whyte D.B., Mellon P.L. Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development 1996, 122:3319-3329.
3. Andrade J., Quinn J., Becker R.Z., Shupnik M.A. AMP-activated protein kinase is a key intermediary in GnRH-stimulated LH gene transcription. Mol. Endocrinol 2013, 27:828-839.
4. Arden K.C., Biggs W.H. Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinase-activated signaling. Arch. Biochem. Biophys 2002, 403:292-298.
5. Arriola D.J., Mayo S.L., Skarra D.V., Benson C.A., Thackray V.G. FOXO1 transcription factor inhibits luteinizing hormone beta gene expression in pituitary gonadotrope cells. J. Biol. Chem 2012, 287:33424-33435.
6. Battiprolu P.K., Hojayev B., Jiang N., Wang Z.V., Luo X., Iglewski M., et al. Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J. Clin. Invest 2012, 122:1109-1118.
7. Belchetz P.E. Gonadotrophin regulation and clinical applications of GnRH. Clin. Endocrinol. Metab 1983, 12:619-640.
8. Brosens J.J., Wilson M.S., Lam E.W. FOXO transcription factors: from cell fate decisions to regulation of human female reproduction. Adv. Exp. Med. Biol 2009, 665:227-241.
9. Brothers K.J., Wu S., DiVall S.A., Messmer M.R., Kahn C.R., Miller R.S., et al. Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor. Cell Metab 2010, 12:295-305.
10. Buggs C., Weinberg F., Kim E., Wolfe A., Radovick S., Wondisford F. Insulin augments GnRH-stimulated LHbeta gene expression by Egr-1. Mol. Cell. Endocrinol 2006, 249:99-106.
11. Calnan D.R., Brunet A. The FoxO code. Oncogene 2008, 27:2276-2288.
12. Chen J., Zhang B., Wong N., Lo A.W., To K.F., Chan A.W., et al. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. Cancer Res 2011, 71:4138-4149.
13. Childs G.V. Growth hormone cells as co-gonadotropes: partners in the regulation of the reproductive system. Trends Endocrinol. Metab 2000, 11:168-175.
14. Childs G.V., Unabia G., Rougeau D. Cells that express luteinizing hormone (LH) and follicle-stimulating hormone (FSH) beta-subunit messenger ribonucleic acids during the estrous cycle: the major contributors contain LH beta, FSH beta, and/or growth hormone. Endocrinology 1994, 134:990-997.
15. Childs G.V., Unabia G., Wu P. Differential expression of growth hormone messenger ribonucleic acid by somatotropes and gonadotropes in male and cycling female rats. Endocrinology 2000, 141:1560-1570.
16. Choi Y.S., Lee H.J., Ku C.R., Cho Y.H., Seo M.R., Lee Y.J., et al. FoxO1 is a negative regulator of follicle stimulating hormone-beta gene expression in basal and gonadotropin-releasing hormone-stimulated conditions in female. Endocrinology 2014, 155:2277-2286.
17. Ciccone N.A., Kaiser U.B. The biology of gonadotroph regulation. Curr. Opin. Endocrinol. Diabetes Obes 2009, 16:321-327.
18. Daitoku H., Sakamaki J., Fukamizu A. Regulation of FoxO transcription factors by acetylation and protein-protein interactions. Biochim. Biophys. Acta 2011, 1813:1954-1960.
19. Dobkin-Bekman M., Naidich M., Rahamim L., Przedecki F., Almog T., Lim S., et al. A pre-formed signaling complex mediates GnRH-activated ERK-phosphorylation of paxillin and FAK at focal adhesions in LbT2 gonadotrope cells. Mol. Endocrinol 2009, 23:1850-1864.
20. Dorn C., Mouillet J.F., Yan X., Ou Q., Sadovsky Y. Insulin enhances the transcription of luteinizing hormone-beta gene. Am. J. Obstet. Gynecol 2004, 191:132-137.
21. Dupont J., McNeilly J., Vaiman A., Canepa S., Combarnous Y., Taragnat C. Activin signaling pathways in ovine pituitary and LbetaT2 gonadotrope cells. Biol. Reprod 2003, 68:1877-1887.
22. Federici M., Porzio O., Zucaro L., Fusco A., Borboni P., Lauro D., et al. Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues. Mol. Cell. Endocrinol 1997, 15:2099-2111.
23. Fowkes R.C., Sidhu K.K., Sosabowski J.K., King P., Burrin J.M. Absence of pituitary adenylate cyclase-activating polypeptide-stimulated transcription of the human glycoprotein alpha-subunit gene in LbetaT2 gonadotrophs reveals disrupted cAMP-mediated gene transcription. J. Mol. Endocrinol 2003, 31:263-278.
24. Furuyama T. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem 2004, 279:34741-34749.
25. Galili N., Davis R.J., Fredericks W.J., Mukhopadhyay S., Rauscher F.J., Emanuel B.S., et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet 1993, 5:230-235.
26. Goertz M.J., Wu Z., Gallardo T.D., Hamra F.K., Castrillon D.H. Foxo1 is required in mouse spermatogonial stem cells for their maintenance and the initiation of spermatogenesis. J. Clin. Invest 2011, 121:3456-3466.
27. Gonzalez E., McGraw T.E. The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 2009, 8:2502-2508.
28. Goto T., Takano M. Transcriptional role of FOXO1 in drug resistance through antioxidant defense systems. Forkhead Transcription Factors. Adv. Exp. Med. Biol 2009, 665:171-179.
29. Guido C., Panza S., Santoro M., Avena P., Panno M.L., Perrotta I., et al. Estrogen receptor beta (ERbeta) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene. Cell Cycle 2012, 11:2911-2921.
30. Gutiérrez S., Mukdsi J.H., Aoki A., Torres A.I., Soler A.P., Orgnero E.M. Ultrastructural immunolocalization of IGF-1 and insulin receptors in rat pituitary culture: evidence of a functional interaction between gonadotroph and lactotroph cells. Cell Tissue Res 2007, 327:121-132.
31. Hariharan N., Maejima Y., Nakae J., Paik J., Depinho R.A., Sadoshima J. Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ. Res 2010, 107:1470-1482.
32. Hedrick S.M., Michelini R.H., Doedens A.L., Goldrath A.W., Stone E.L. FOXO transcription factors throughout T cell biology. Nat. Rev. Immunol 2012, 12:649-661.
33. Hemmings B.A., Restuccia D.F. PI3K-PKB/Akt pathway. Cold Spring Harb. Perspect. Biol 2012, 4:a011189.
34. Horvath E., Kovacs K. Fine structural cytology of the adenohypophysis in rat and man. J. Electron Microsc. Tech 1988, 8:401-432.
35. Hosaka T., Biggs W.H., Tieu D., Boyer A.D., Varki N.M., Cavenee W.K., et al. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. U. S. A 2004, 101:2975-2980.
36. Huang H., Tindall D.J. Dynamic FoxO transcription factors. J. Cell Sci 2007, 120:2479-2487.
37. Huhtaniemi I. Mutations along the pituitary-gonadal axis affecting sexual maturation: novel information from transgenic and knockout mice. Mol. Cell. Endocrinol 2006, 254-255:84-90.
38. Huhtaniemi I., Ahtiainen P., Pakarainen T., Rulli S.B., Zhang F.P., Poutanen M. Genetically modified mouse models in studies of luteinising hormone action. Mol. Cell. Endocrinol 2006, 252:126-135.
39. Kajihara T., Brosens J.J., Ishihara O. The role of FOXO1 in the decidual transformation of the endometrium and early pregnancy. Med. Mol. Morphol 2013, 46:61-68.
40. Katic M., Kahn C.R. The role of insulin and IGF-1 signaling in longevity. Cell. Mol. Life Sci 2005, 62:320-343.
41. Kitamura T. The role of FOXO1 in β-cell failure and type 2 diabetes mellitus. Nat. Rev. Endocrinol 2013, 9:615-623.
42. Kousteni S. FoxO1: a molecule for all seasons. J. Bone Miner. Res 2011, 26:912-917.
43. Kousteni S. FoxO1, the transcriptional chief of staff of energy metabolism. Bone 2012, 50:437-443.
44. Lam E.W.F., Brosens J.J., Gomes A.R., Koo C.-Y. Forkhead box proteins: tuning forks for transcriptional harmony. Nat. Rev. Cancer 2013, 13:482-495.
45. Lamminen T., Jokinen P., Jiang M., Pakarinen P., Simonsen H., Huhtaniemi I. Human FSH beta subunit gene is highly conserved. Mol. Hum. Reprod 2005, 11:601-605.
46. Lappas M., Lim R., Riley C., Rice G.E., Permezel M. Localisation and expression of FoxO1 proteins in human gestational tissues. Placenta 2009, 30:256-262.
47. Lew M. Good statistical practice in pharmacology. Problem 2. Br. J. Pharmacol 2007, 152:299-303.
48. Lindsley C.W., Zhao Z., Leister W.H., Robinson R.G., Barnett S.F., Defeo-Jones D., et al. Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. Bioorg. Med. Chem. Lett 2005, 15:761-764.
49. Liu Z., Castrillon D.H., Zhou W., Richards J.S. FOXO1/3 depletion in granulosa cells alters follicle growth, death and regulation of pituitary FSH. Mol. Endocrinol 2013, 27:238-252.
50. Majumdar S., Farris C.L., Kabat B.E., Jung D.O., Ellsworth B.S. Forkhead Box O1 is present in quiescent pituitary cells during development and is increased in the absence of p27 Kip1. PLoS ONE 2012, 7:e52136.
51. Matsuzaki H., Daitoku H., Hatta M., Aoyama H., Yoshimochi K., Fukamizu A. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11278-11283.
52. Michaelis K.A., Knox A.J., Xu M., Kiseljak-Vassiliades K., Edwards M.G., Geraci M., et al. Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors. Endocrinology 2011, 152:3603-3613.
53. Miller R.S., Wolfe A., He L., Radovick S., Wondisford F.E. CREB binding protein (CBP) activation is required for luteinizing hormone beta expression and normal fertility in mice. Mol. Cell. Biol 2012, 32:2349-2358.
54. Monsalve M., Olmos Y. The complex biology of FOXO. Curr. Drug Targets 2011, 12:1322-1350.
55. Mosthaf L., Grako K., Dull T.J., Coussens L., Ullrich A., McClain D.A. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J. 1990, 9:2409-2413.
56. Myers M.G., White M.F. Insulin signal transduction and the IRS proteins. Annu. Rev. Pharmacol. Toxicol 1996, 36:615-658.
57. Nakae J., Park B.C., Accili D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J. Biol. Chem 1999, 274:15982-15985.
58. Nakae J., Barr V., Accili D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J. 2000, 19:989-996.
59. Nakamura N., Ramaswamy S., Vazquez F., Signoretti S., Loda M., Sellers W.R. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol 2000, 20:8969-8982.
60. Naor Z. Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor. Front. Neuroendocrinol 2009, 30:10-29.
61. Navratil A.M., Song H., Hernandez J.B., Cherrington B.D., Santos S.J., Low J.M., et al. Insulin augments gonadotropin-releasing hormone induction of translation in LbetaT2 cells. Mol. Cell. Endocrinol 2009, 311:47-54.
62. Ooi G.T., Tawadros N., Escalona R.M. Pituitary cell lines and their endocrine applications. Mol. Cell. Endocrinol 2004, 228:1-21.
63. Ouyang W., Liao W., Luo C.T., Yin N., Huse M., Kim M.V., et al. Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 2012, 491:554-559.
64. Pierce J.G., Parsons T.F. Glycoprotein hormones: structure and function. Ann. Rev. Biochem 1981, 50:465-495.
65. Puthanveetil P., Wan A., Rodrigues B. FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival. Cardiovasc. Res 2013, 97:393-403.
66. Rena G., Prescott A.R., Guo S., Cohen P., Unterman T.G. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting. Biochem. J. 2001, 354:605-612.
67. Rose A., Froment P., Perrot V., Quon M.J., LeRoith D., Dupont J. The luteinizing hormone-releasing hormone inhibits the anti-apoptotic activity of insulin-like growth factor-1 in pituitary alphaT3 cells by protein kinase Calpha-mediated negative regulation of Akt. J. Biol. Chem 2004, 279:52500-52516.
68. Seeburg P.H., Mason A.J., Stewart T.A., Nikolics K. The mammalian GnRH gene and its pivotal role in reproduction. Recent Prog. Horm. Res 1987, 43:69-98.
69. Skarra D.V., Arriola D.J., Benson C.A., Thackray V.G. Forkhead box O1 is a repressor of basal and GnRH-induced Fshb transcription in gonadotropes. Mol. Endocrinol 2013, 27:1825-1839.
70. Soldani R., Cagnacci A., Yen S.S. Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. Eur. J. Endocrinol 1994, 131:641-645.
71. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol 2006, 7:85-96.
72. Thackray V.G. Fox tales: regulation of gonadotropin gene expression by forkhead transcription factors. Mol. Cell. Endocrinol 2013, 385:62-70.
73. Thackray V.G., Mellon P.L., Coss D. Hormones in synergy: regulation of the pituitary gonadotropin genes. Mol. Cell. Endocrinol 2010, 314:192-203.
74. Tikhanovich I., Cox J., Weinman S.A. Forkhead box class O transcription factors in liver function and disease. J. Gastroenterol. Hepatol 2013, 1:125-131.
75. van der Vos K.E., Coffer P.J. FOXO-binding partners: it takes two to tango. Oncogene 2008, 27:2289-2299.
76. Vale W., Rivier C., Brown M. Regulatory peptides of the hypothalamus. Ann. Rev. Physiol 1977, 39:473-527.
77. Weiss J.M., Polack S., Diedrich K., Ortmann O. Effects of insulin on luteinizing hormone and prolactin secretion and calcium signaling in female rat pituitary cells. Arch. Gynecol. Obstet 2003, 269:45-50.
78. Windle J.J., Weiner R.I., Mellon P.L. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol. Endocrinol 1990, 4:597-603.
79. Yao X.H., Nguyen H.K., Nyomba B.L. Prenatal ethanol exposure causes glucose intolerance with increased hepatic gluconeogenesis and histone deacetylases in adult rat offspring: reversal by tauroursodeoxycholic acid. PLoS ONE 2013, 8:e59680.
80. Zhang X., Tang N., Hadden T.J., Rishi A.K. Akt, FoxO and regulation of apoptosis. Biochim. Biophys. Acta 2011, 1813:1978-1986.
81. Zhao Y., Yang J., Liao W., Liu X., Zhang H., Wang S., et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat. Cell Biol 2010, 12:665-675.
82. Zhao Z., Leister W.H., Robinson R.G., Barnett S.F., Defeo-Jones D., Jones R.E., et al. Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors. Bioorg. Med. Chem. Lett 2005, 15:905-909.